NCT00274287 2019-03-28GM-CSF for Maintenance of Prostate Cancer for Patients Responding to TaxotereOncology Specialists, S.C.Phase 2 Completed15 enrolled 12 charts
NCT00477087 2017-11-29Phase II GM-CSF Plus Mitoxantrone in Hormone Refractory Prostate CancerStanford UniversityPhase 2 Terminated10 enrolled 10 charts